These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 1521828)
1. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His). Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency. Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin. Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution. Loreth RM; Meyer M; Albert FW Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution. Ebert RF; Schreiler WE; Bell WR Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization. Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia. Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution. Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products. Vila V; Regañón E; Aznar J; Navarro G; Salas M Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261 [TBL] [Abstract][Full Text] [Related]
10. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain]. Rupp C; Sievi R; Furlan M; Beck EA Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427 [TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release. Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution. Borrell M; Vila L; Solá J; Coll I; Fontcuberta J Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia. Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [TBL] [Abstract][Full Text] [Related]
16. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization. Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159 [TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
19. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Furlan M; Leupin L; Biasiutti FD; Lämmle B Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701 [TBL] [Abstract][Full Text] [Related]
20. Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II. Borrell M; Vila L; Solá J; Coll I; Gómez N; González N; Rutllant ML Thromb Res; 1987 Mar; 45(5):591-9. PubMed ID: 3109061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]